-
Loading metrics
Open Access
Peer-reviewed
Research Article
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
-
Minu K. Srivastava,
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Li Zhu,
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Marni Harris-White,
Affiliation Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Upendra Kar,
Affiliation Department of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America
⨯ -
Min Huang,
Affiliation Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Ming F. Johnson,
Affiliation Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Jay M. Lee,
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America
⨯ -
David Elashoff,
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America
⨯ -
Robert Strieter,
Affiliation Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Steven Dubinett,
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯ -
Sherven Sharma
* E-mail: ssharma@mednet.ucla.edu
Affiliations Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America
⨯
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
- Minu K. Srivastava,
- Li Zhu,
- Marni Harris-White,
- Upendra Kar,
- Min Huang,
- Ming F. Johnson,
- Jay M. Lee,
- David Elashoff,
- Robert Strieter,
- Steven Dubinett
- Published: July 16, 2012
- https://doi.org/10.1371/journal.pone.0040677